New drug blocks pancreatic cancer growth in mice, study finds
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai. The study, published recently in the journal Gastroenterology, also demonstrated in mice that the drug, called Metavert, may prevent patients from developing a resistance to currently used pancreatic cancer chemotherapies.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Cancer | Cancer & Oncology | Gastroenterology | Laboratory Medicine | Pancreas | Pancreatic Cancer | Pharmaceuticals | Study